Uri Wormser

Prof. Uri Wormser


Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 July 2005 in Archives of Toxicology
Verified
Journal Article
Closed access
PDF file
UWUri Wormser
Uri Wormser
BBBerta Brodsky
Berta Brodsky
EPElena Proscura
Elena Proscura
JFJulie F. Foley
Julie F. Foley
TJTinette Jones
Tinette Jones
ANAbraham Nyska
Abraham Nyska

1 November 2000 in Toxicology and Applied Pharmacology
Verified
Journal Article
Closed access
UWUri Wormser
Uri Wormser
ASAmnon Sintov
Amnon Sintov
BBBerta Brodsky
Berta Brodsky
ANAbraham Nyska
Abraham Nyska

1 March 2002 in Archives of Toxicology
Verified
Journal Article
Closed access
PDF file
UWUri Wormser
Uri Wormser
BBBerta Brodsky
Berta Brodsky
RRReuven Reich
Reuven Reich

15 November 2003 in Archives of Toxicology
Verified
Journal Article
Closed access
PDF file
UWUri Wormser
Uri Wormser
ASAmnon Sintov
Amnon Sintov
BBBerta Brodsky
Berta Brodsky
RCRobert P. Casillas
Robert P. Casillas
ANAbraham Nyska
Abraham Nyska

27 October 2005 in Archives of Toxicology
Verified
Journal Article
Closed access
PDF file
BBBerta Brodsky
Berta Brodsky
STSheetal Trivedi
Sheetal Trivedi
SPShyamal Peddada
Shyamal Peddada
NFNorris Flagler
Norris Flagler
UWUri Wormser
Uri Wormser
ANAbraham Nyska
Abraham Nyska

1 June 2016 in Journal of Neuroinflammation
Verified
Journal Article
Open access
PDF file
UWUri Wormser
Uri Wormser
JESSICA MANDRIOLIJESSICA MANDRIOLI
JESSICA MANDRIOLI
Marco VincetiMarco Vinceti
Marco Vinceti
NFNicola Fini
Nicola Fini
ASAmnon Sintov
Amnon Sintov
YFYoram Finkelstein
Yoram Finkelstein
Amyotrophic lateral sclerosis (ALS) is an incurable neurodegenerative motor neuron disease that involves activation of the immune system and inflammatory response in the nervous system. Reduced level of the immuno-modulatory and anti-inflammatory protein alpha-1-antitrypsin (AAT) is associated with inflammation-related pathologies. The objective of the present is to determine AAT levels and IL-23 in the cerebrospinal fluid (CSF) of ALS patients and control group. CSF samples from newly diagnosed ALS patients and age-matched controls were analyzed for AAT and IL-23 by ELISA and magnetic luminex screening, respectively. A statistically significant reduction of 45 % in mean AAT levels was observed in the CSF of ALS patients (21.4 μg/ml) as compared to the control group (mean 38.8 μg/ml, p = 0.013). A statistically significant increase of 30.8 % in CSF mean levels of the pro-inflammatory cytokine IL-23 was observed in ALS patients (1647 pg/ml) in comparison to the controls (1259 pg/ml, p = 0.012). A negative correlation coefficient (r = −0.543) was obtained by linear regression analysis of the two measured parameters (p = 0.036). Reduced AAT and elevated IL-23 CSF levels support the notion of neuroinflammatory process occurring in ALS patients. Increasing AAT levels in the patients’ nervous system should be further investigated as a new therapeutic approach and a novel potential tool for ALS treatment.